BACKGROUND: The failure of approximately 20 % of obese patients who undergo Roux-en-Y gastric bypass (RYGB) to maintain weight loss over the following 18-24 months is related to the surgical procedure, to the patient, or both. Although the underlying mechanisms are uncertain, one factor that has been postulated is the dilation of the gastrojejunal anastomosis. The objective was to evaluate the safety and efficacy of the serial use of argon plasma coagulation (APC) in reducing the diameter of the dilated gastrojejunal anastomosis and post-RYGB weight regain. METHODS: We carried out a prospective, nonrandomized study of 30 patients, with no control or sham group, monitoring RYGB weight regain associated with dilation of the gastrojejunal anastomosis over a postoperative period of 18 months. Each patient underwent three sessions of APC in the anastomosis separated by 8 weeks, with a final endoscopic examination 8 weeks after the last session. RESULTS: There was a loss of 15.48 kg (range = 8.0-16.0 kg) of the 19.6 kg (range = 7.0-39.0 kg) of regained weight after RYGB and a reduction of 66.89 % in the final anastomotic diameter, with statistically significant reductions between each APC session. Previous body mass index significantly decreased up to the final examination, and the final weight was close to but not at the same level as the nadir. CONCLUSIONS: Our study indicates that the use of APC to treat weight regain after RYGB is a safe and effective procedure and promotes a reduction in gastrojejunal anastomosis, final weight, and BMI, with a low rate of complications.
BACKGROUND: The failure of approximately 20 % of obesepatients who undergo Roux-en-Y gastric bypass (RYGB) to maintain weight loss over the following 18-24 months is related to the surgical procedure, to the patient, or both. Although the underlying mechanisms are uncertain, one factor that has been postulated is the dilation of the gastrojejunal anastomosis. The objective was to evaluate the safety and efficacy of the serial use of argon plasma coagulation (APC) in reducing the diameter of the dilated gastrojejunal anastomosis and post-RYGB weight regain. METHODS: We carried out a prospective, nonrandomized study of 30 patients, with no control or sham group, monitoring RYGB weight regain associated with dilation of the gastrojejunal anastomosis over a postoperative period of 18 months. Each patient underwent three sessions of APC in the anastomosis separated by 8 weeks, with a final endoscopic examination 8 weeks after the last session. RESULTS: There was a loss of 15.48 kg (range = 8.0-16.0 kg) of the 19.6 kg (range = 7.0-39.0 kg) of regained weight after RYGB and a reduction of 66.89 % in the final anastomotic diameter, with statistically significant reductions between each APC session. Previous body mass index significantly decreased up to the final examination, and the final weight was close to but not at the same level as the nadir. CONCLUSIONS: Our study indicates that the use of APC to treat weight regain after RYGB is a safe and effective procedure and promotes a reduction in gastrojejunal anastomosis, final weight, and BMI, with a low rate of complications.
Authors: Mario P Morales; Andrew A Wheeler; Archana Ramaswamy; J Stephen Scott; Roger A de la Torre Journal: Surg Obes Relat Dis Date: 2010-01-01 Impact factor: 4.734
Authors: Daniel M Herron; Desmond H Birkett; Chris C Thompson; Marc Bessler; Lee L Swanström Journal: Surg Endosc Date: 2007-11-20 Impact factor: 4.584
Authors: Barham K Abu Dayyeh; Pichamol Jirapinyo; Zachary Weitzner; Charlotte Barker; Michael S Flicker; David B Lautz; Christopher C Thompson Journal: Gastrointest Endosc Date: 2012-08 Impact factor: 9.427
Authors: Santiago Horgan; Garth Jacobsen; G Derek Weiss; John S Oldham; Peter M Denk; Frank Borao; Steven Gorcey; Brad Watkins; John Mobley; Kari Thompson; Adam Spivack; Dave Voellinger; Chris Thompson; Lee Swanstrom; Paresh Shah; Greg Haber; Matthew Brengman; Gregory Schroder Journal: Surg Obes Relat Dis Date: 2010-02-13 Impact factor: 4.734
Authors: Daniel McKenna; Don Selzer; Michael Burchett; Jennifer Choi; Samer G Mattar Journal: Surg Obes Relat Dis Date: 2013-12-18 Impact factor: 4.734
Authors: Lea Fayad; Michael Schweitzer; Micheal Raad; Cem Simsek; Roberto Oleas; Margo K Dunlap; Tazkia Shah; Jay Doshi; Margueritta El Asmar; Andreas Oberbach; Vikesh K Singh; Kimberly Steele; Thomas Magnussen; Anthony N Kalloo; Mouen A Khashab; Vivek Kumbhari Journal: Obes Surg Date: 2019-07 Impact factor: 4.129
Authors: Rena C Moon; Andre F Teixeira; Manoel Galvao Neto; Natan Zundel; Bruno Queiroz Sander; Flavio Mitidieri Ramos; Felipe Matz; Giorgio A Baretta; Luiz Gustavo de Quadros; Eduardo Grecco; Thiago Souza; Sergio A Barrichello; Admar Concon Filho; Eduardo Nobuyuki Usuy; Artagnan Menezes Barbosa de Amorim; Muhammad A Jawad Journal: Obes Surg Date: 2018-09 Impact factor: 4.129
Authors: Maria Paula Carlin Cambi; Giorgio Alfredo Pedroso Baretta; Daniéla De Oliveira Magro; Cesar Luiz Boguszewski; Igor Braga Ribeiro; Pichamol Jirapinyo; Diogo Turiani Hourneaux de Moura Journal: Obes Surg Date: 2021-01-03 Impact factor: 4.129
Authors: Pichamol Jirapinyo; Diogo T H de Moura; William Y Dong; Galileu Farias; Christopher C Thompson Journal: Gastrointest Endosc Date: 2020-01-03 Impact factor: 9.427